Methylenetetrahydrofolate reductase gene polymorphism and its association with coronary artery disease
Keywords:
Coronary arteriosclerosis, Atherosclerosis, Methylenetetrahydrofolate reductase (NADPH2), Polymorphism genetic, HomocysteineAbstract
CONTEXT AND OBJECTIVE: Obstructive coronary artery disease (CAD) is characterized by the deposition of atherosclerotic plaque on the coronary artery wall. Its manifestations depend on interactions between environmental and genetic risk factors. The aim of this work was to analyze the frequency of methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism in patients with CAD and its association with plasma homocysteine levels. Risk factors for CAD were also evaluated. DESIGN AND SETTING: Retrospective with blind quantitative analysis, at Hospital de Base, Faculdade de Medicina de São José do Rio Preto. METHODS: One hundred and twenty-seven individuals were studied. All completed a questionnaire to analyze risk factors for CAD. MTHFR polymorphism was investigated by restriction fragment length analysis and correlated with the number of affected arteries and degree of arterial obstruction determined by coronary cineangiography, and with plasma homocysteine levels measured by liquid chromatography/sequential mass spectrometry. RESULTS: Smoking (p = 0.02) and high-density lipoprotein cholesterol (p = 0.01) were associated with CAD. The C allele was the most prevalent in patients (0.61) and controls (0.66). There was no correlation between MTHFR/C677T polymorphism and plasma homocysteine levels. However, in patients with the TT genotype there was a correlation with the prevalence of coronary obstruction greater than 95% (p = 0.02) and the presence of two affected arteries (p = 0.04). CONCLUSIONS: The TT genotype is associated with coronary artery obstruction greater than 95% and the presence of two affected arteries. This confi rms the relationship between genetic variants in specific patient subgroups and cardiovascular diseases.
Downloads
References
Aire S, Garcia DP, Kajita LJ, Rati AM. Estudo hemodinâmico e cineangiográfico. Sociedade de Cardiologia do Estado de São Paulo. Cardiologia: atualização e reciclagem. Rio de Janeiro: Atheneu; 1994. p. 159-71.
Andreassi MG, Botto N, Cocci F, et al. Methylenetetrahydro- folate reductase gene C677T polymorphism, homocysteine, vitamin B12, and DNA damage in coronary artery disease. Hum Genetic. 2003;112(2):171-7.
Doevendans PA, Jukema W, Spiering W, Defesche JC, Kastelein JJ. Molecular genetics and gene expression in atherosclerosis. Int J Cardiol. 2001;80(2-3):161-72.
Arruda VR, Siqueira LH, Gonçalves MS, et al. Prevalence of the mutation C677-- > T in the methylene tetrahydrofolate reductase gene among distinct ethnic groups in Brazil. Am J Med Genet. 1998;78(4):332-5.
Robinson K, Mayer EL, Miller DP, et al. Hyperhomocystein- emia and low pyridoxal phosphate. Common and independent reversible risk factors for coronary artery disease. Circulation. 1995;92(10):2825-30.
Hofmann MA, Lalla E, Lu Y, et al. Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model. J Clin Invest. 2001;107(6):675-83.
Hankey GJ, Eikelboom JW. Homocysteine and vascular disease. Lancet. 1999;354(9176):407-13.
Lobo A, Naso A, Arheart K, et al. Reduction of homocysteine levels in coronary artery disease by low-dose folic acid combined with vitamins B6 and B12. Am J Cardiol. 1999;83(6):821-5.
Bova I, Chapman J, Sylantiev C, Korczyn AD, Bornstein NM. The A677V methylenetetrahydrofolate reductase gene polymor- phism and carotid atherosclerosis. Stroke. 1999;30(10):2180-2.
Welch GN, Upchurch G Jr, Loscalzo J. Hyperhomocyst(e)inemia and atherothrombosis. Ann N Y Acad Sci. 1997;811:48-58; discussion 58-9.
Tyagi SC. Homocysteine redox receptor and regulation of extracellular matrix components in vascular cells. Am J Physiol. 1998;274(2 Pt 1)C396-405.
Abdel-Rahman SZ, Nouraldeen AM, Ahmed AE. Molecular interaction of [2,3-14C] acrylonitrile with DNA in gastric tissues of rat. J Biochem Toxicol. 1994;9(4):191-8.
Beiguelman B. Curso prático de bioestatística. Ribeirão Preto: FUNPEC; 1996.
Alagona C, Soro A, Westerbacka J, et al. Low HDL choles- terol concentration is associated with increased intima-media thickness independent of arterial stiffness in healthy subjects from families with low HDL cholesterol. Eur J Clin Invest. 2003;33(6):457-63.
von Birgelen C, Hartmann M, Mintz GS, Baumgart D, Schmermund A, Erbel R. Relation between progression and regression of atherosclerotic left main coronary artery disease and serum cholesterol levels as assessed with serial long-term (> or =12 months) follow-up intravascular ultrasound. Circulation. 2003;108(22):2757-62.
Rassoul F, Richter V, Janke C, et al. Plasma homocysteine and lipoprotein profile in patients with peripheral arterial occlusive disease. Angiology. 2000;51(3):189-96.
Souza DR, Campos BF, Arruda EF, Yamamoto LJ, Trindade DM, Tognola WA. Influence of polymorphism of apolipoprotein E in cerebral vascular disease. Arq Neuropsiquiatr. 2003;61(1):7-13.
Pereira AC, Schettert IT, Morandini Filho AA, Guerra-Shi- nohara EM, Krieger JE. Methylenetetrahydrofolate reductase (MTHFR) c677t gene variant modulates the homocysteine folate correlation in a mild folate-deficient population. Clin Chim Acta. 2004;340(1-2):99-105.
Rudisch B, Nemeroff CB. Epidemiology of comorbid coronary artery disease and depression. Biol Psychiatry. 2003;54(3):227-40.
Morita H, Taguchi J, Kurihara H, et al. Genetic polymorphism of 5,10-methylenetetrahydrofolate reductase (MTHFR) as a risk fac- tor for coronary artery disease. Circulation. 1997;95(8):2032-6.
Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahy- drofolate reductase. Nat Genet. 1995;10(1):111-3.
Brattström L, Wilcken DE, Ohrvik J, Brudin L. Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: the result of a meta-analysis. Circulation. 1998;98(23):2520-6.
Schwartz SM, Siscovick DS, Malinow MR, et al. Myocardial infarction in young women in relation to plasma total homo- cysteine, folate, and a common variant in the methylenetetra- hydrofolate reductase gene. Circulation. 1997;96(2):412-7.
Morelli VM, Lourenço DM, D’Almeida V, et al. Hyperhomocy- steinemia increases the risk of venous thrombosis independent of the C677T mutation of the methylenetetrahydrofolate reductase gene in selected Brazilian patients. Blood Coagul Fibrinolysis. 2002;13(3):271-5.
Franco RF, Araújo AG, Guerreiro JF, Elion J, Zago MA. Analysis of the 677 C-->T mutation of the methylenetetrahydrofolate reductase gene in different ethnic groups. Thromb Haemost. 1998;79(1):119-21.
Lobo A, Naso A, Arheart K, et al. Reduction of homocysteine levels in coronary artery disease by low-dose folic acid combined with vitamins B6 and B12. Am J Cardiol. 1999;83(6):821-5.
